C
Chunghwa Chemical Synthesis & Biotech Co Ltd
TWSE:1762
Chunghwa Chemical Synthesis & Biotech Co Ltd
TWSE:1762
Price:
28.1
TWD
1.81%
Market Closed
Market Cap:
NT$2.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Chunghwa Chemical Synthesis & Biotech Co Ltd
TWSE:1762
|
TW |
Income Statement
Earnings Waterfall
Chunghwa Chemical Synthesis & Biotech Co Ltd
Chunghwa Chemical Synthesis & Biotech Co Ltd
Income Statement
Chunghwa Chemical Synthesis & Biotech Co Ltd
Chunghwa Chemical Synthesis & Biotech Co Ltd
Currency: TWD
| Jun-2010 | Sep-2010 | Dec-2010 | Mar-2011 | Jun-2011 | Sep-2011 | Dec-2011 | Mar-2012 | Jun-2012 | Sep-2012 | Dec-2012 | Mar-2013 | Jun-2013 | Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest Expense |
12
|
10
|
10
|
8
|
6
|
4
|
2
|
2
|
4
|
7
|
10
|
12
|
13
|
12
|
12
|
12
|
13
|
13
|
14
|
14
|
12
|
10
|
8
|
7
|
7
|
7
|
7
|
6
|
6
|
7
|
8
|
10
|
12
|
12
|
11
|
10
|
9
|
10
|
11
|
11
|
10
|
8
|
5
|
2
|
0
|
2
|
3
|
5
|
8
|
9
|
8
|
10
|
12
|
19
|
20
|
22
|
22
|
21
|
20
|
18
|
17
|
|
| Revenue |
1 527
N/A
|
1 619
+6%
|
1 197
-26%
|
1 174
-2%
|
1 185
+1%
|
1 179
0%
|
1 201
+2%
|
1 224
+2%
|
1 362
+11%
|
1 374
+1%
|
1 320
-4%
|
1 339
+1%
|
1 155
-14%
|
1 043
-10%
|
1 044
+0%
|
995
-5%
|
965
-3%
|
923
-4%
|
947
+3%
|
945
0%
|
995
+5%
|
1 098
+10%
|
1 162
+6%
|
1 181
+2%
|
1 185
+0%
|
1 254
+6%
|
1 199
-4%
|
1 204
+0%
|
1 100
-9%
|
1 127
+2%
|
1 168
+4%
|
1 172
+0%
|
1 313
+12%
|
1 131
-14%
|
1 019
-10%
|
1 087
+7%
|
1 074
-1%
|
1 113
+4%
|
1 157
+4%
|
1 120
-3%
|
1 193
+6%
|
1 260
+6%
|
1 544
+22%
|
1 658
+7%
|
1 766
+7%
|
1 987
+13%
|
1 935
-3%
|
2 043
+6%
|
2 122
+4%
|
2 082
-2%
|
1 811
-13%
|
1 758
-3%
|
1 631
-7%
|
2 086
+28%
|
1 573
-25%
|
1 507
-4%
|
1 517
+1%
|
1 347
-11%
|
1 289
-4%
|
1 171
-9%
|
978
-17%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(1 053)
|
(1 111)
|
(745)
|
(721)
|
(750)
|
(759)
|
(747)
|
(743)
|
(800)
|
(788)
|
(789)
|
(822)
|
(709)
|
(650)
|
(669)
|
(651)
|
(642)
|
(647)
|
(650)
|
(684)
|
(736)
|
(775)
|
(756)
|
(713)
|
(714)
|
(781)
|
(784)
|
(813)
|
(741)
|
(717)
|
(760)
|
(760)
|
(859)
|
(762)
|
(668)
|
(693)
|
(684)
|
(683)
|
(688)
|
(667)
|
(656)
|
(703)
|
(857)
|
(872)
|
(913)
|
(1 025)
|
(985)
|
(1 044)
|
(1 107)
|
(1 098)
|
(992)
|
(1 050)
|
(1 024)
|
(1 329)
|
(1 047)
|
(1 020)
|
(1 043)
|
(953)
|
(951)
|
(922)
|
(826)
|
|
| Gross Profit |
474
N/A
|
508
+7%
|
452
-11%
|
453
+0%
|
435
-4%
|
420
-3%
|
454
+8%
|
481
+6%
|
562
+17%
|
586
+4%
|
531
-9%
|
516
-3%
|
446
-14%
|
393
-12%
|
375
-5%
|
344
-8%
|
323
-6%
|
277
-14%
|
297
+7%
|
261
-12%
|
259
-1%
|
323
+25%
|
406
+26%
|
468
+15%
|
471
+1%
|
473
+0%
|
414
-12%
|
391
-6%
|
360
-8%
|
410
+14%
|
408
0%
|
412
+1%
|
454
+10%
|
369
-19%
|
352
-5%
|
394
+12%
|
390
-1%
|
429
+10%
|
469
+9%
|
453
-3%
|
536
+18%
|
557
+4%
|
687
+23%
|
786
+14%
|
853
+9%
|
962
+13%
|
949
-1%
|
998
+5%
|
1 015
+2%
|
984
-3%
|
819
-17%
|
707
-14%
|
607
-14%
|
757
+25%
|
526
-31%
|
487
-7%
|
474
-3%
|
394
-17%
|
338
-14%
|
249
-26%
|
152
-39%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(280)
|
(282)
|
(246)
|
(246)
|
(253)
|
(271)
|
(285)
|
(314)
|
(327)
|
(330)
|
(319)
|
(309)
|
(290)
|
(280)
|
(276)
|
(276)
|
(273)
|
(274)
|
(273)
|
(277)
|
(286)
|
(299)
|
(307)
|
(315)
|
(318)
|
(319)
|
(316)
|
(316)
|
(317)
|
(322)
|
(330)
|
(329)
|
(340)
|
(323)
|
(321)
|
(338)
|
(340)
|
(354)
|
(348)
|
(346)
|
(353)
|
(367)
|
(418)
|
(435)
|
(440)
|
(477)
|
(511)
|
(523)
|
(543)
|
(527)
|
(379)
|
(383)
|
(379)
|
(476)
|
(437)
|
(405)
|
(388)
|
(388)
|
(360)
|
(349)
|
(335)
|
|
| Selling, General & Administrative |
(138)
|
(140)
|
(145)
|
(144)
|
(147)
|
(152)
|
(155)
|
(163)
|
(175)
|
(185)
|
(183)
|
(180)
|
(169)
|
(154)
|
(150)
|
(147)
|
(143)
|
(143)
|
(143)
|
(148)
|
(156)
|
(164)
|
(175)
|
(176)
|
(174)
|
(174)
|
(170)
|
(174)
|
(176)
|
(177)
|
(180)
|
(177)
|
(184)
|
(167)
|
(159)
|
(158)
|
(149)
|
(153)
|
(152)
|
(153)
|
(157)
|
(165)
|
(202)
|
(214)
|
(220)
|
(246)
|
(258)
|
(260)
|
(274)
|
(265)
|
(204)
|
(203)
|
(192)
|
(234)
|
(203)
|
(185)
|
(181)
|
(182)
|
(166)
|
(158)
|
(151)
|
|
| Research & Development |
(105)
|
(105)
|
(101)
|
(103)
|
(106)
|
(120)
|
(131)
|
(144)
|
(153)
|
(146)
|
(136)
|
(129)
|
(121)
|
(126)
|
(127)
|
(129)
|
(131)
|
(131)
|
(130)
|
(130)
|
(130)
|
(128)
|
(132)
|
(139)
|
(143)
|
(144)
|
(146)
|
(143)
|
(141)
|
(145)
|
(149)
|
(152)
|
(155)
|
(156)
|
(162)
|
(170)
|
(182)
|
(191)
|
(195)
|
(193)
|
(196)
|
(201)
|
(216)
|
(154)
|
(154)
|
(165)
|
(253)
|
(263)
|
(269)
|
(262)
|
(176)
|
(180)
|
(187)
|
(243)
|
(234)
|
(219)
|
(205)
|
(206)
|
(194)
|
(190)
|
(184)
|
|
| Other Operating Expenses |
(37)
|
(37)
|
0
|
0
|
0
|
0
|
0
|
(7)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(10)
|
(10)
|
(10)
|
0
|
0
|
0
|
0
|
0
|
(67)
|
(67)
|
(67)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
194
N/A
|
227
+17%
|
206
-9%
|
207
+1%
|
182
-12%
|
149
-18%
|
169
+13%
|
167
-1%
|
234
+40%
|
256
+9%
|
212
-17%
|
208
-2%
|
157
-25%
|
113
-28%
|
99
-13%
|
68
-32%
|
50
-26%
|
3
-94%
|
23
+734%
|
(17)
N/A
|
(27)
-63%
|
24
N/A
|
100
+313%
|
153
+53%
|
154
+1%
|
154
+0%
|
98
-36%
|
75
-24%
|
43
-43%
|
88
+107%
|
78
-11%
|
84
+7%
|
115
+37%
|
45
-60%
|
31
-32%
|
56
+81%
|
50
-11%
|
75
+51%
|
121
+61%
|
107
-12%
|
183
+71%
|
190
+4%
|
269
+41%
|
351
+31%
|
413
+18%
|
484
+17%
|
438
-9%
|
476
+8%
|
472
-1%
|
458
-3%
|
439
-4%
|
324
-26%
|
228
-30%
|
281
+23%
|
89
-68%
|
83
-8%
|
86
+5%
|
6
-93%
|
(23)
N/A
|
(100)
-336%
|
(184)
-84%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(15)
|
(15)
|
(25)
|
(19)
|
(20)
|
5
|
15
|
8
|
14
|
(13)
|
(13)
|
(3)
|
(7)
|
(3)
|
2
|
(2)
|
(8)
|
(1)
|
3
|
(5)
|
(3)
|
9
|
4
|
3
|
9
|
(13)
|
(6)
|
(14)
|
(14)
|
(7)
|
23
|
34
|
31
|
34
|
(3)
|
9
|
18
|
17
|
15
|
13
|
19
|
24
|
26
|
28
|
15
|
19
|
41
|
53
|
96
|
138
|
113
|
85
|
48
|
43
|
60
|
48
|
21
|
41
|
24
|
(4)
|
41
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
(7)
|
(7)
|
(7)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(6)
|
(6)
|
0
|
(7)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(10)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
84
|
0
|
86
|
86
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(0)
|
233
|
233
|
0
|
233
|
(0)
|
0
|
0
|
0
|
1
|
0
|
0
|
(0)
|
0
|
0
|
0
|
215
|
0
|
0
|
0
|
0
|
0
|
347
|
0
|
347
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Total Other Income |
5
|
8
|
12
|
100
|
18
|
18
|
14
|
13
|
11
|
11
|
12
|
13
|
16
|
15
|
13
|
11
|
11
|
15
|
12
|
12
|
9
|
238
|
7
|
9
|
6
|
6
|
0
|
(3)
|
(3)
|
(1)
|
9
|
8
|
10
|
225
|
7
|
223
|
221
|
6
|
8
|
7
|
7
|
352
|
9
|
355
|
12
|
21
|
19
|
19
|
19
|
9
|
10
|
5
|
8
|
10
|
7
|
8
|
7
|
10
|
13
|
13
|
12
|
|
| Pre-Tax Income |
185
N/A
|
220
+19%
|
276
+26%
|
288
+4%
|
259
-10%
|
252
-3%
|
194
-23%
|
188
-3%
|
259
+38%
|
254
-2%
|
211
-17%
|
218
+3%
|
166
-24%
|
125
-24%
|
114
-9%
|
77
-32%
|
53
-31%
|
16
-69%
|
38
+134%
|
217
+473%
|
206
-5%
|
272
+32%
|
336
+24%
|
164
-51%
|
169
+3%
|
147
-13%
|
93
-37%
|
59
-37%
|
26
-55%
|
81
+210%
|
110
+35%
|
126
+15%
|
157
+24%
|
305
+95%
|
240
-21%
|
288
+20%
|
289
+1%
|
99
-66%
|
144
+45%
|
127
-12%
|
556
+338%
|
566
+2%
|
650
+15%
|
734
+13%
|
440
-40%
|
525
+19%
|
498
-5%
|
547
+10%
|
587
+7%
|
605
+3%
|
562
-7%
|
414
-26%
|
284
-31%
|
333
+18%
|
156
-53%
|
138
-11%
|
114
-18%
|
57
-50%
|
15
-73%
|
(91)
N/A
|
(129)
-42%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
(20)
|
(33)
|
(27)
|
(32)
|
(8)
|
(3)
|
(29)
|
(28)
|
(48)
|
(47)
|
(35)
|
(34)
|
(25)
|
(20)
|
(17)
|
(10)
|
(7)
|
1
|
(23)
|
(14)
|
(14)
|
(25)
|
(28)
|
(39)
|
(56)
|
(53)
|
(33)
|
(28)
|
(8)
|
(15)
|
(24)
|
(25)
|
(28)
|
(19)
|
(6)
|
(16)
|
(19)
|
(23)
|
(27)
|
(23)
|
(94)
|
(96)
|
(118)
|
(131)
|
(83)
|
(116)
|
(97)
|
(116)
|
(135)
|
(118)
|
(114)
|
(85)
|
(63)
|
(69)
|
(30)
|
(20)
|
(16)
|
(4)
|
4
|
22
|
26
|
|
| Income from Continuing Operations |
165
|
187
|
249
|
256
|
251
|
248
|
166
|
159
|
210
|
207
|
176
|
184
|
141
|
105
|
97
|
67
|
46
|
17
|
15
|
204
|
193
|
247
|
308
|
125
|
112
|
94
|
60
|
31
|
19
|
67
|
86
|
102
|
129
|
286
|
234
|
272
|
270
|
76
|
117
|
104
|
461
|
470
|
532
|
603
|
358
|
408
|
401
|
431
|
452
|
488
|
448
|
330
|
221
|
265
|
126
|
118
|
98
|
53
|
20
|
(69)
|
(103)
|
|
| Income to Minority Interest |
(1)
|
(2)
|
(62)
|
(62)
|
(61)
|
(61)
|
6
|
5
|
5
|
5
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
164
N/A
|
185
+13%
|
187
+1%
|
194
+4%
|
190
-2%
|
188
-1%
|
171
-9%
|
165
-4%
|
216
+31%
|
212
-2%
|
176
-17%
|
184
+5%
|
141
-23%
|
105
-26%
|
97
-8%
|
67
-31%
|
46
-32%
|
17
-63%
|
15
-15%
|
204
+1 295%
|
193
-5%
|
246
+28%
|
308
+25%
|
125
-59%
|
112
-10%
|
94
-16%
|
60
-36%
|
31
-49%
|
19
-40%
|
67
+261%
|
86
+29%
|
101
+18%
|
129
+27%
|
286
+123%
|
234
-18%
|
272
+16%
|
270
-1%
|
76
-72%
|
117
+54%
|
104
-11%
|
461
+345%
|
470
+2%
|
532
+13%
|
602
+13%
|
358
-41%
|
408
+14%
|
401
-2%
|
430
+7%
|
452
+5%
|
488
+8%
|
448
-8%
|
330
-26%
|
221
-33%
|
265
+20%
|
126
-52%
|
118
-7%
|
98
-17%
|
53
-46%
|
20
-63%
|
(69)
N/A
|
(103)
-50%
|
|
| EPS (Diluted) |
2.29
N/A
|
2.61
+14%
|
2.61
N/A
|
2.5
-4%
|
2.44
-2%
|
2.4
-2%
|
2.2
-8%
|
2.12
-4%
|
2.78
+31%
|
2.73
-2%
|
2.26
-17%
|
2.37
+5%
|
1.81
-24%
|
1.35
-25%
|
1.24
-8%
|
0.86
-31%
|
0.59
-31%
|
0.22
-63%
|
0.19
-14%
|
2.62
+1 279%
|
2.48
-5%
|
3.17
+28%
|
3.96
+25%
|
1.6
-60%
|
1.43
-11%
|
1.2
-16%
|
0.77
-36%
|
0.4
-48%
|
0.24
-40%
|
0.86
+258%
|
1.1
+28%
|
1.3
+18%
|
1.65
+27%
|
3.68
+123%
|
2.99
-19%
|
3.49
+17%
|
3.47
-1%
|
0.97
-72%
|
1.5
+55%
|
1.33
-11%
|
5.93
+346%
|
6.04
+2%
|
6.79
+12%
|
7.71
+14%
|
4.59
-40%
|
5.23
+14%
|
5.12
-2%
|
5.5
+7%
|
5.79
+5%
|
6.22
+7%
|
5.77
-7%
|
4.23
-27%
|
2.82
-33%
|
3.39
+20%
|
1.62
-52%
|
1.51
-7%
|
1.25
-17%
|
0.94
-25%
|
0.35
-63%
|
-1.23
N/A
|
-1.86
-51%
|
|
Switch to:
Switch to:
See Also
Discover More
